Liz McKee Anderson

Liz McKee Anderson has a long and varied work experience. Liz began in 2011 as a Board of Trustees member and Executive Committee Co-Chair at The Wistar Institute. In 2015, they joined REVOLUTION Medicines as a Member of the Board of Directors and Chair of the Compensation Committee. In 2017, they joined Bavarian Nordic as a Board of Directors Member. In 2018, they joined Aro Biotherapeutics Company as an Independent Board Director, Chair of the Compensation Committee, and Member of the Audit Committee. Liz also joined Insmed Incorporated in 2018 as a Member of the Board of Directors and Chair of the Nominations and Governance Committee. In 2019, they joined BioMarin Pharmaceutical Inc. as a Member of the Board of Directors and Member of the Audit Committee and Corporate Governance Committee. In 2018, they also joined Context Therapeutics as a Member of the Board of Directors. In 2018, they joined Huntsworth PLC as a Non Executive Director. Finally, in 2009, they joined Johnson & Johnson, Infectious Diseases & Vaccines as Worldwide Vice President, Commercial Leader and Worldwide Vice President, Global Strategic Marketing and Market Access, Vaccines. In 2022, they will join GSK as Non-Executive Director, Member of Audit and Risk, and Remuneration Committees.

Liz McKee Anderson obtained their Bachelor of Engineering (BEng) from Rutgers University between 1975 and 1979 in the field of Engineering and Technical Management. Liz then went on to obtain their Master of Business Administration (MBA) from Loyola University Maryland between 1979 and 1982, specializing in Finance.